Daily as of 3 Nov 16:00 ET
- Price
- between the two $49.41 vs 50 $58.42 / 200 $46.83
- Projection
- 💀Death cross estimated in 20 to 30 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 18 Sep 2025 · projected 22 bars out
TVTX | Travere TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$49.41
+$0.15 (+0.30%)
Travere Therapeutics (TVTX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Sep 2025, but the two have been closing on each other and a death cross is projected within 30 bars. Price sits between the 50 and the 200 on the daily, above both on the weekly and below both on the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $50.39 vs 50 $44.56 / 200 $22.49
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 25 Aug 2025 · projected 30 bars out · tested 2 bars
4-hour as of 3 Nov 16:00 ET
- Price
- below both $49.41 vs 50 $52.55 / 200 $58.31
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 19 Oct 2026 · projected 24 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 19 Oct 2026 | 💀Death | 4-hour | 24 bars out | Not tested |
| 22 Apr 2026 | 🟨Golden | 4-hour | 13 bars out | Not tested |
| 10 Feb 2026 | 💀Death | 4-hour | 21 bars out | — |
| 18 Sep 2025 | 🟨Golden steep | daily | 22 bars out | Not tested |
| week of 25 Aug 2025 | 🟨Golden moderate | weekly | 30 bars out | 2 bar cross test |
About TVTX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$90.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandmid